Navigation Links
Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results
Date:2/8/2008

MINNEAPOLIS, Feb. 8 /PRNewswire-FirstCall/ -- Hawkins, Inc. (Nasdaq: HWKN) today announced third quarter and nine months results for fiscal 2008. For the quarter ended December 31, 2007, Hawkins reported sales increased 30.9% to $48.5 million versus $37.0 million for the same period a year ago. Net income for the quarter was $1.5 million, equal to $0.15 per diluted share, versus net income of $314,000, or $0.03 per diluted share for the third quarter of fiscal 2007.

For the nine months ended December 31, 2007, Hawkins reported sales of $145.2 million compared to sales of $120.7 million in the prior year period, an increase of 20.3%. Net income for the nine-month period ended December 31, 2007 was $7.4 million compared to $6.3 million in the prior year period, an increase of 17.9%. Diluted earnings per share rose to $0.72 compared to $0.62 per diluted share for the same period a year ago, an increase of 16.1%.

Industrial segment sales increased by $20.3 million or 29.2% for the nine months ended December 31, 2007, driven largely by an increase in higher volume, lower margin products, price increases commensurate with rising material costs, and the acquisition of Trumark, Inc.

Water Treatment segment sales increased by $3.6 million or 8.2% for the nine months ended December 31, 2007, primarily attributable to selling price increases commensurate with rising material costs, expansion of existing product lines to new and existing customers and volume increases during the first quarter of fiscal 2008 related to favorable weather conditions.

Gross margin as a percent of sales for the three and nine months ended December 31, 2007 were 18.8% and 22.6%, respectively, compared with 18.9% and 24.0% in the comparable periods a year ago. The decreases were primarily due to a change in product mix towards higher volume, lower margin products and higher material costs. The decrease for the three months ended December 31, 2007 was partially mitigated by the LIFO method of valuing inventory, which negatively impacted gross margins in the third quarter of fiscal 2007.

Net income for the nine-month period was positively impacted by higher sales, partially offset by increased expenses, principally Selling, General, and Administrative (SG&A) expenses related to consultant and contractor fees for system enhancements and the acquisition of Trumark, which were augmented by growth in sales and support personnel. SG&A expenses, as a percentage of sales, decreased for both the quarter, 14.4% this year versus 18.1% in the prior year, and nine months, 15.1% this year compared with 16.4% last year.

Chief Executive Officer, John R. Hawkins, commented, "Hawkins' sales continue to grow. However, increased material costs have resulted in continuing pressure on our margins. The success that we have generated thus far in fiscal 2008, along with the investments we are making to strengthen both Hawkins' infrastructure and competitive position, should bode well for our future. In January of 2008, two new Water Treatment sales and service offices were established in Missouri and Kansas, further expanding Hawkins' territory and creating new business opportunities."

Hawkins, Inc. provides a full range of bulk industrial products complemented with the technical competence and innovation to formulate and blend specialty chemicals. The Company sells and services related products and equipment to safely dispense chemicals in highly controlled environments.

Hawkins serves customers in a wide range of industries, including chemical processing, electronics, energy, environmental services, food processing, metal finishing, pharmaceutical, medical devices, pulp and paper, and water treatment.

Hawkins is headquartered in Minneapolis, Minnesota. The Company operates eighteen facilities in Iowa, Illinois, Kansas, Minnesota, Missouri, Montana, Nebraska, New Jersey, South and North Dakota and Wisconsin and services customers in Upper Michigan and Wyoming as well.

The discussion above contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements by their nature involve substantial risks and uncertainties. Actual results may differ materially depending on a variety of factors, including, but not limited to, the following: our ability to pass through cost increases in raw materials and energy, competition from other chemical companies, seasonality and weather conditions, costs and difficulties with our new enterprise resource planning system, the hazards of chemical manufacturing, natural disasters, downturns in our customers' industries, actual growth in our products' markets, changes in our customers' products, compliance with applicable laws and regulations, our ability to meet quality specifications, the adequacy of our insurance coverage, our ability to attract and retain key personnel, our ability to complete and integrate future acquisitions, and future terrorist attacks. Additional information with respect to the risks and uncertainties faced by Hawkins may be found in, and the prior discussion is qualified in its entirety by, the Risk Factors contained in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 1, 2007, as updated by subsequent SEC filings.

HAWKINS, INC.

CONDENSED STATEMENTS OF INCOME

(unaudited)

Three Months Ended Nine Months Ended

December 31, December 31, December 31, December 31,

2007 2006 2007 2006

Sales $48,471,758 $37,039,181 $145,238,339 $120,700,006

Cost of sales 39,335,817 30,047,975 112,396,348 91,709,068

Gross margin 9,135,941 6,991,206 32,841,991 28,990,938

Selling, general and

administrative

expenses 6,958,489 6,716,617 21,952,418 19,835,758

Income from

operations 2,177,452 274,589 10,889,573 9,155,180

Investment income 257,468 359,184 872,036 1,008,188

Income before income

taxes 2,434,920 633,773 11,761,609 10,163,368

Provision for income

taxes 927,967 319,500 4,382,167 3,903,000

Net income $1,506,953 $314,273 $7,379,442 $6,260,368

Weighted average

number of shares

outstanding -

basic 10,216,632 10,171,496 10,204,609 10,171,496

Weighted average

number of shares

outstanding -

diluted 10,217,997 10,171,715 10,205,075 10,171,570

Earnings per share -

basic and diluted $0.15 $0.03 $0.72 $0.62

Cash dividends

declared per common

share -- -- $0.24 $0.22


'/>"/>
SOURCE Hawkins, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bioniche Reports Fiscal 2008 Second Quarter
2. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
3. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
4. Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Womens Health Watch
5. Pathology Reports Good for Breast Cancer Studies
6. American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
7. J.D. Power and Associates Reports: The Nebraska Medical Center Recognized for Providing an Outstanding Inpatient Experience for a Third Consecutive Year, and for Providing an Outstanding Cardiovascular Experience
8. HCA Reports Fourth Quarter - Year End 2007 Results
9. MedCath Corporation Reports First Quarter Earnings
10. DRAXIS Health Reports Fourth Quarter and Year End Results
11. PPD Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: